World Kidney Day 2024 | Cromos Pharma
World Kidney Day 2024 World Kidney Day is an  annual global event on the second Thursday of March, focusing on raising awareness about kidney health and the impact of kidney diseases on individual well-being. Since its inception in 2006, it has evolved into a significant global health movement, spotlighting the substantial global health impact of kidney disease, a leading Read more
Clinical Research Focus 26th edition | Cromos Pharma
Clinical Research Focus. 26th Edition Navigating the Future of Gene Therapy In January 2024, the FDA issued a guidance document, outlining critical considerations in the clinical development of CRISPR/CAS9 drug candidates. This guidance addresses the nuanced challenges associated with the development of human gene-edited (GE) products, placing particular emphasis on mitigating risks linked to both the gene therapy product itself Read more
Celebrating Rare Disease Day 2024 | Cromos Pharma
Celebrating Rare Disease Day 2024 Today, on Rare Disease Day, we emphasize the importance of bringing attention to conditions that, though rare, affect millions around the world. A striking total of over 440 million people globally face these diseases, underlining the critical need for increased advocacy and decisive action. Currently, the world benefits from the availability of over 500 drugs Read more
Clinical Research Focus 25th edition | Cromos Pharma
Clinical Research Focus. 25th Edition J.P. Morgan’s Healthcare Conference: A Glimpse into the Optimistic Pulse of 2024 The biopharmaceutical industry, emerged from 2023’s continued downturn in finance deals and mergers and acquisitions (M&A) and showcased resilience and determination at the 2024 J.P. Morgan Conference. Notable M&A deals were heralded, signifying if not a recovery, at least a beacon of hope Read more

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM